Safety Profile of Paxlovid in the Treatment of COVID-19
Description
CONCLUSION: This study indicates that the most common AEs reported with Paxlovid in post-marketing experience are consistent with the safety assessment of antiviral drugs. Even without emerging apparent safety concerns, the incidence of serious
